Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis

Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely... J Gastroenterol (2017) 52:1031–1040 DOI 10.1007/s00535-017-1325-2 ORI G INAL ARTI CL E—ALIMENTARY T R ACT Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis 1 2 3 4 • • • • Yasuo Suzuki Satoshi Motoya Hiroyuki Hanai Toshifumi Hibi 5 6 7 7 • • • • Shiro Nakamura Andreas Lazar Anne Martin Robinson Martha Skup 7 7 7 8 • • • Nael Mohamed Mostafa Bidan Huang Roopal Thakkar Mamoru Watanabe Received: 30 September 2016 / Accepted: 26 February 2017 / Published online: 20 March 2017 The Author(s) 2017. This article is an open access publication Abstract hybrid nonresponder imputation (hNRI) method. Nonre- Background The 52-week safety and efficacy of adali- sponder imputation was used for missing data up to the mumab in Japanese patients with moderately to severely latest possible follow-up date for each patient, followed by active ulcerative colitis were demonstrated in a placebo- observed case. Adalimumab trough concentrations were controlled phase 2/3 trial. Data from patients who enrolled reported from week 52 to week 196 of treatment. Treat- in the open-label extension study are presented. ment-emergent adverse events were reported for all adali- Methods Remission and response per http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Gastroenterology Springer Journals

Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis

Loading next page...
 
/lp/springer_journal/four-year-maintenance-treatment-with-adalimumab-in-japanese-patients-VoaabbzG4U
Publisher
Springer Journals
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Gastroenterology; Hepatology; Abdominal Surgery; Colorectal Surgery; Surgical Oncology
ISSN
0944-1174
eISSN
1435-5922
D.O.I.
10.1007/s00535-017-1325-2
Publisher site
See Article on Publisher Site

Abstract

J Gastroenterol (2017) 52:1031–1040 DOI 10.1007/s00535-017-1325-2 ORI G INAL ARTI CL E—ALIMENTARY T R ACT Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis 1 2 3 4 • • • • Yasuo Suzuki Satoshi Motoya Hiroyuki Hanai Toshifumi Hibi 5 6 7 7 • • • • Shiro Nakamura Andreas Lazar Anne Martin Robinson Martha Skup 7 7 7 8 • • • Nael Mohamed Mostafa Bidan Huang Roopal Thakkar Mamoru Watanabe Received: 30 September 2016 / Accepted: 26 February 2017 / Published online: 20 March 2017 The Author(s) 2017. This article is an open access publication Abstract hybrid nonresponder imputation (hNRI) method. Nonre- Background The 52-week safety and efficacy of adali- sponder imputation was used for missing data up to the mumab in Japanese patients with moderately to severely latest possible follow-up date for each patient, followed by active ulcerative colitis were demonstrated in a placebo- observed case. Adalimumab trough concentrations were controlled phase 2/3 trial. Data from patients who enrolled reported from week 52 to week 196 of treatment. Treat- in the open-label extension study are presented. ment-emergent adverse events were reported for all adali- Methods Remission and response per

Journal

Journal of GastroenterologySpringer Journals

Published: Mar 20, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off